* ContraFect Corp CFRX.OQ CFRX.O is expected to show no
change in quarterly revenue when it reports results on November
15 (estimated).
* Refinitiv's mean analyst estimate for ContraFect Corp is for
a loss of 28 cents per share. For the same quarter last year,
the company reported earnings of 12 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for ContraFect Corp
is $14, about 70.6% above its last closing price of $4.11.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2021 -0.30 -0.28 -0.14 Beat 50
Mar. 31 2021 -0.22 -0.22 -0.18 Beat 18.2
Dec. 31 2020 -0.27 -0.31 -0.23 Beat 24.8
Sep. 30 2020 -0.34 -0.38 0.12 Beat 131.4
Jun. -0.34 -0.37 -0.88 Missed -139.1
30 2020
Mar. 31 2020 -0.64 -0.62 -0.49 Beat 21
Dec. 31 2019 -0.65 -0.83 -1.11 Missed -33.7
Sep. 30 2019 -0.75 -0.77 -0.70 Beat 9.7
This summary was machine generated November 12 at 17:10 GMT.
All figures in US dollars unless otherwise stated